Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance Discoveries of Biopharmaceutical Innovations at Leading U.S. Academic Research Institutions
Allied Minds Forms University Research Venture with Bristol - Myers
Research and Markets: Global PCOS (Stein-Leventhal Syndrome) Drugs Market 2014-2018
Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products
Cortendo Appoints Matthew Pauls as Chief Executive Officer
There is more competition among dividend-growth funds, making it harder to truly stand out.
StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.
Widening investment-grade credit spreads and rising interest rates lead to losses.